Head and Neck Neoplasms Clinical Trials

286 clinical trials for Head and Neck Neoplasms across international registries, including 29 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer — RECRUITING · PHASE2
• Biospecimen Procurement for Head and Neck Disorders — RECRUITING
• Methylation Profile Test (Methylscape) in Body Fluids for Multi-Cancer Detection and Monitoring in Colombia — RECRUITING
• Intratumoral N17350 in Advanced Solid Tumors — RECRUITING · PHASE1
• Foot Reflexology and Ta-VNS for Symptom Management in Head and Neck Cancer During CCRT — RECRUITING · NA
• The SNAP Tool for Head and Neck Cancer Survivor-Caregiver Dyads — RECRUITING · NA
• A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer — RECRUITING · PHASE2
• The SWOAR Trial Sparing of Swallowing and Aspiration Related Organs at Risk & Submandibular Gland With Intensity Modulated Radiotherapy Versus Standard IMRT in Head and Neck Squamous Cell Carcinomas — RECRUITING · PHASE3
• Preventive Physical Activity Intervention in Head and Neck Cancer — RECRUITING · NA
• The EMINENCE Study - PET/MR Imaging of Head Neck Cancer — RECRUITING
• Molecular and Genomic Profiling of Head and Neck Tumors — RECRUITING
• Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis — RECRUITING · NA
• The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study — RECRUITING
• Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study — RECRUITING · NA
• Head and Neck Cancer Study Project in the Geriatric Population — RECRUITING · PHASE3
• Dose Finding Study of Zanzalintinib With Pembrolizumab and Cetuximab in Head and Neck SCC — RECRUITING · PHASE1
• NIDCD Otolaryngology Clinical Protocol Biospecimen Bank — RECRUITING
• DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-Adjustment — RECRUITING · PHASE4
• Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors — RECRUITING · PHASE1
• HTL0039732 in Participants With Advanced Solid Tumours — RECRUITING · PHASE1
• Open Label Phase 2 Basket Trial With Atezolizumab and Tiragolumab in Solid Tumors — RECRUITING · PHASE2
• Upfront Surgery Vs Induction Chemotherapy Followed By Surgery In Oral Cancers: — RECRUITING · PHASE3
• Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial — RECRUITING · NA
• EMST in Patients Undergoing CRT for HNCA — RECRUITING · NA
• Arabic PRO Measures for Head and Neck Cancer Radiotherapy. — RECRUITING
• Adaptive Radiotherapy in Head and Neck Tumor Patients — RECRUITING · NA
• The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD) — RECRUITING
• Feasibility Testing a Decision-support Intervention for Clinical Trials — RECRUITING · NA
• Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN — RECRUITING · PHASE2
• Heavy Strength Training in Head and Neck Cancer Survivors — COMPLETED · PHASE2
• A Phase 1/2 Study of KSQ-001EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate the SOCS1 Gene, in Patients With Select Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) — ACTIVE_NOT_RECRUITING · PHASE3
• A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 — ACTIVE_NOT_RECRUITING · PHASE2
• Durvalumab (MEDI4736) With Cetuximab in Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma — COMPLETED · PHASE2
• Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck — WITHDRAWN · PHASE1
• First in Human Study of AZD9592 in Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• Exploratory Study on the Efficacy and Safety of Trastuzumab Rezetecan in the Treatment of HER2-Expressiong Advanced Solid Tumor — NOT_YET_RECRUITING · PHASE2
• An Exploratory Study of Zanidatamab in HER2-positive Advanced Tumor After at Least One Line of Standard Therapy — NOT_YET_RECRUITING · PHASE2
• Evaluation of Two Methods of Administration of Photobiomodulation in the Context of the Prevention and Treatment of Mucositis Induced by Radiotherapy, During the Treatment of Head and Neck Cancers — NOT_YET_RECRUITING · NA
• Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients — ACTIVE_NOT_RECRUITING · NA
• Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) — ACTIVE_NOT_RECRUITING · PHASE2
• Collection of Head Images During Radiotherapy — COMPLETED
• Prognostic Evaluation of 18fmiso Pet-ct in Head and Neck Cancer — COMPLETED · NA
• Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy — ACTIVE_NOT_RECRUITING · PHASE1
• Atezolizumab and Bevacizumab in Patients With Recurrent or Metastatic Squamous-cell Carcinoma of the Head and Neck — COMPLETED · PHASE2
• Expanded Access [11C] Methionine PET Imaging — OTHER
• Study of Xevinapant With Radiation and Chemotherapy for Patients With Head and Neck Cancer — TERMINATED · PHASE1
• Exercise Prehabilitation in Patients With Head and Neck Squamous-cell Carcinoma: The FIT4TREAT Trial — COMPLETED · NA
• Factors Sustaining Tobacco Abstinence in Cancer Patients Treated With Radio-chemotherapy or Radiotherapy — ACTIVE_NOT_RECRUITING
• A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) — TERMINATED · PHASE3

Refine this search